account_balance
Investment manager · 13F filer · SEC CIK 1744967
Samsara Biocapital, LLC
Reported value$1.22Bas of Jun 30, 2026
Positions24 4 new, 2 sold out
Top 10 weight90.5%SRRK alone is 31%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
The top 10 stocks are 90.5% of this fund. 14 other stocks make up the rest.
SRRK Scholar Rock HLDG Corp 31.2% HeldALMS Alumis Inc 14.7% HeldMLYS Mineralys Therapeutics Inc 13.0% HeldSEPN Septerna Inc 8.7% HeldALMR Alamar Biosciences Inc 5.5% NewNGNE Neurogene Inc 4.4% HeldKLRS Kalaris Therapeutics Inc 4.3% HeldSGP Spyglass Pharma Inc 3.9% HeldSTRO Sutro Biopharma Inc 2.9% HeldIVA Inventiva SA 2.0% Added +22%
14 other stocks9.5%
Bar length compares each stock with the biggest holding. Tags compare share counts with the Mar 31, 2026 filing. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed